loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Maharashtra FDA has cancelled the drug sale and distribution licences of Cipla Pharma

ICICIdirect Research 05 Oct 2026 DISCLAIMER

News: Maharashtra FDA has cancelled the drug sale and distribution licences of Cipla Pharma & Life Sciences’ carrying and forwarding warehouse at Wadki, Pune, citing alleged regulatory violations. The action follows fresh proceedings conducted in compliance with Bombay High Court directions. Earlier, the FDA had flagged irregularities in the packaging, storage, documentation and recall of Reactin Plus Tablets, including unauthorised claims on the packaging of the Schedule H drug.

View: This drug is being manufactured at a third-party site at Haridwar. Cipla Pharma & Life Sciences is a trade generics arm of Cipla and contributes ~15% to the Cipla domestic sales. Since the issue does not pertain to the manufacturing site and is related to c&f warehouse, we do not expect material impact. We expect the management we address the issue on priority.

Impact: Neutral

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere